NovoCure Ltd — Director's Dealing 2019

Mar 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-02-27

Reporting Person: Kirson Eilon D. (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-27	Ordinary Shares	M	6945	$52.90	Acquired	152408	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-27	Restricted Stock Units	$0.00	M	6945	Disposed		Ordinary Shares (6945)	Direct

Footnotes

F1: Fully vested as of the date hereof.